Abstract
Two workflows are presented that are relevant to the design and construction of end-to-end pharmaceutical manufacturing processes. The workflows target the very early stage crystallisation aspect of these processes-production of the primary crystalline solid form-and relate to establishing decision-driven approaches for the screening for multi-component forms, specifically co-crystals, and to the use of additives to control crystal and primary particle form, notably morphology. These workflows are shown to benefit from the use of the million-plus structures in the Cambridge structural database and the associated structural informatics and analysis tools and are placed into the context of the work of the CMAC Future Manufacturing Hub.
Original language | English |
---|---|
Pages (from-to) | 7475-7489 |
Number of pages | 15 |
Journal | CrystEngComm |
Volume | 22 |
Issue number | 43 |
Early online date | 22 Sept 2020 |
DOIs | |
Publication status | Published - 21 Nov 2020 |
Bibliographical note
Funding Information:This research was funded under the EPSRC grant EP/ P006965/1 and by a University of Bath studentship (PP). The authors would like to thank CMAC colleagues at Strathclyde, Leeds and Loughborough and both Dr. Pete Wood and Dr. Andy Moloney at the CCDC for valuable discussions.
Publisher Copyright:
© 2020 The Royal Society of Chemistry.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
ASJC Scopus subject areas
- General Chemistry
- General Materials Science
- Condensed Matter Physics
Fingerprint
Dive into the research topics of 'From structure to crystallisation and pharmaceutical manufacturing: The CSD in CMAC workflows'. Together they form a unique fingerprint.Equipment
-
Differential Scanning Calorimeter (DSC)
Material and Chemical Characterisation (MC2)Facility/equipment: Equipment
-
Powder X-Ray Diffractometer (PXRD)
Material and Chemical Characterisation (MC2)Facility/equipment: Equipment